The bacterium chlamydia trachomatis can be detected directly with this is new antigen test. This means that this test is also suitable for further check-ups following successful treatment.

The chlamydia trachomatis infection is the most common sexually transmitted disease. This mostly asymptomatic disease is the greatest cause of infection-induced infertility.
An infection can lead to various symptoms and later complications: in women it can cause cervicitis, urethitis, peritoneal symptoms or sterility. In men it can lead to urethritis, prostatitis or epididymitis, and in new-born babies can cause newborn pneumonia or inclusion conjunctivitis.

If the chlamydia trachomatis infection is detected in the early stages, it can prevent later complications such as sterility or the development of other illnesses. For patients this new method of diagnosis enables higher quality treatment.

The chlamyCARE-C test system includes all instruments for use: sterile swabs (one for preparation and one for sample collection), test cassette and buffer bottles A & B. It is not necessary to incubate the sample at 80 C.

chlamyCARE-C detects the presence of antigens already with a 1.6x10 to the power of 4 elementary corpuscles/ml and records - according to clinical user trials - 85.7% sensitivity and 98.3% specificity rates (results in comparison with PCR (Polymerase Chain Reaction)).


20 test cassettes
Extraction buffer A & B
20 sample containers

Sample volume: Swab (Dacron)
Evidence: Chlamydia tr. Antigen, serotypes AK; LGVI-LGV111
Methodology: Quick immunochromatographic test
Sample type: Endourethal or endocervical smear



test pack for cervical smear inc. swab



test pack for urethral smear inc. swab



pack, no swabs



sterile swabs, individually wrapped, for cervical smear



sterile swabs, individually wrapped, for urethral smear